Over the last three years we have had a significant government-funded vaccine development program. Some of the resulting products have been sold to local vaccine companies and may be available for sub-licensing; some are in the final stages of development.

  • Actinobacillus pleuropneumonia (APP) bacterin
  • Actinobacillus pleuropneumonia (APP) subunit vaccine
  • Mycoplasma hyopneumoniae subunit vaccine
  • Mycoplasma hyorhinis subunit vaccine
  • Mycoplasma hyopneumoniae / Mycoplasma hyorhinis bivalent bacterin
  • Mycoplasma hyopneumoniae / Porcine circovirus type 2 (PCV2) bivalent subunit vaccine
  • Porcine circovirus type 2 (PCV2) subunit vaccine
  • Porcine epidemic diarrhea virus (PEDV) subunit vaccine
  • Porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine
  • Salmonella cholerasuis attenuated vaccine

Products for Mycoplasma hyopneumoniae vaccines on the market

Several vaccines are currently at proof of concept stage.

  • Mycoplasma gallisepticum bacterin
  • Mycoplasma gallisepticum subunit vaccine
  • Mycoplasma synoviae bacterin
  • Mycoplasma synoviae subunit vaccine